Edward Hu

Callidus Biopharma, Inc. develops drug discovery services. The firm focuses on enzyme replacement therapies (ERTs) for lysosomal storage disorders (LSDs). Its novel technology platform is based on attaching a form of the naturally occurring Insulin-like growth factor (IGF-2) to enhance the targeting of therapeutic enzymes to the relevant cells in the body. The company was founded by Cuong Viet Do and Hung Do in 2010 and is headquartered in Bensalem, PA.

Vivace Therapeutics, Inc. discovers and develops novel cancer drug. The company was founded by Shuang Qiao in 2014 and is headquartered in San Mateo, CA.

Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA.

Shanghai Syn-the-all Pharmaceutical Co. Ltd. engages in the manufacture, research and development of generic drugs. The company offers active pharmaceutical ingredients and finished forms. It provides API process development, small molecule Active pharmaceutical ingredients, analytical development and quality control, antibody drug conjugate services. It serves life science industry. Shanghai Syn-the-all Pharmaceutical was founded on January 23, 2003 and is headquartered in Shanghai, China.

6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017.

Wuxi Apptec, Inc. provides pharmaceutical and biotechnology services. Its services include discovery, lab testing division, small molecule pharmaceutical development and manufacturing international discovery service unit, WuXi biologics, chemistry, bioanalytical, clinical & regulatory, genome center, biological reagents and WuXi venture fund. The company was founded by Ge Li in December 2000 and is headquartered in St. Paul, MN.

TenNor Therapeutics Suzhou Ltd. manufactures pharmaceutical products. It specializes in research and development of new drugs for the treatment of digestive diseases caused by pathogens, including those resistant to available antibiotics. The company was founded by Zhen Kun Ma in 2013 and is headquartered in Suzhou, China.

LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA.

Wuxi Biologics Holdings Ltd. functions as an investment holding There is no available country named vg company.

Wuxi New Life Science Investment Ltd. is a Chinese company that provides investment services. The private company is based in Shanghai, China.

Viela Bio, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatment for autoimmune and inflammatory diseases. The firms product candidate includes inebilizumab, which is a humanized monoclonal antibody (mAb), designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells; VIB4920, which is a fusion protein designed to bind to CD40L on activated T cells, blocking their interaction with CD40-expressing B cells and potentially other binding partners; and VIB7734, which is a humanized mAb intended to be a novel treatment for autoimmune diseases where the pathology is driven principally by overproduction of type I interferons and other cytokines secreted by pDCs. The company was founded on December 11, 2017 and is headquartered in Gaithersburg, MD.

JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China.

Part of WuXi AppTec Co., Ltd., WuXi Apptec UK Ltd. is a private company that engages in technical testing, analysis, and provides research and experimental development on biotechnology. The company is based in London, UK and was founded in 2011.

Hua Medtech Medical Devices (Shanghai) Co., Ltd. provides stroke diagnosis, treatment, and rehabilitation services. The private company is based in Shanghai, China. The Chinese company was founded in 2017. Wei Zhang has been the CEO of the company since 2020.

Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA.

Suzhou Borui Chuanghe Pharmaceutical Co., Ltd. is a company based in Suzhou, China that provides research and development solutions for radionuclide-targeted drugs. The Chinese company was founded in 2018 and the CEO is Jiang Bin Hu.

Phagelux, Inc. develops anti-bacterial solutions. It specializes across multiple fields utilizing various phage and phage-based technologies and solutions. The company is headquartered in Shanghai, China.